OBJECTIVES: Cardiac arrest (CA) in patients with acute myocardial infarction is associated with a poor prognosis. Due to the additional trauma, risk of stroke and lack of data, coronary artery bypass grafting (CABG) is a controversial revascularization strategy for patients who cannot be treated percutaneously. Against this background, we investigated the outcome of patients from our department with acute myocardial infarction undergoing CABG after CA.
INTRODUCTION
Patients with cardiac arrest (CA) due to acute myocardial infarction (AMI) represent a challenge because of the persistently high rates of mortality and morbidity [1] . The hypothesis that fast myocardial reperfusion is crucial in this setting is based on the idea that this treatment restores haemodynamic stability, thereby providing perfusion of organs particularly vulnerable to hypoxic damage such as the brain. Although large randomized prospective studies are yet to be conducted, this concept has been supported by several observational trials, demonstrating the positive impact on survival of patients with CA after treatment with percutaneous transluminal angioplasty (PTCA) [2] [3] [4] [5] . However, these studies simultaneously show that survival is significantly reduced when coronary disease is present, but PTCA is not performed or fails. In these patients, who may comprise up to 10% of the CA patient population, the clinical approach is unclear and seldom reported on. The possibility of myocardial revascularization by coronary bypass graft surgery (CABG) in CA patients has traditionally been considered with the utmost reluctance by many cardiologists and cardiac surgeons. Exposure of these patients to a procedure that is associated with additional trauma, a potentially septicaemic, inflammatory haemodynamic state and increased risk of stroke appears to be even more disconcerting than the reservations felt towards CABG in patients with AMI not complicated by CA. Accordingly, only a few articles have dealt with this procedure. Surprisingly, these studies report an almost †The last two authors contributed equally to this work.
unbelievably good outcome compared with trials with resuscitated patients treated primarily with PTCA, but a profound selection bias must be anticipated [6] [7] [8] . Considering the persistently high numbers of deaths and the neurological dysfunction of patients with CA, the increasing knowledge about the potential benefits of the early implantation of an extracorporeal life support (ECLS) system as well as controlled mild systemic hypothermia in resuscitated patients-2 hallmarks of on-pump CABG procedures-the question arises whether the operative strategy is better than its reputation. This study analyses the outcome of pre-operatively resuscitated AMI patients who underwent emergency CABG at our institution.
METHODS

Data source
Our department provides cardiac surgical care for all hospitals and practices throughout the federal state of Schleswig-Holstein. The institutional AMI registry was started in 2001. It currently includes the data of approximately 1100 patients who have had CABG within 48 h after being diagnosed with AMI. Elective procedures as well as operations performed beyond this period of time were excluded from the analysis. Between January 2001 and January 2015, 129 of these patients had a CA preoperatively. In addition to the 30-day mortality rate, follow-up data were obtained from those who survived beyond that day. Data were collected by contacting the respective patients by mail and phone. In cases where patients or relatives did not respond, the patient's general physician was interviewed. If the patient's whereabouts still remained unknown, the public records office was contacted. Cerebral performance category (CPC) scales were estimated based on direct information provided by patients or relatives, ambulatory visits performed during the follow-up period or discharge letters provided by the institution that most recently treated the patient. The study was approved by the ethics committee of the medical faculty of the University of Kiel.
Surgical management
A standard median sternotomy and total cardiopulmonary bypass with moderate hypothermic circulatory arrest were performed in all, except in 1 patient. Patients were routinely cooled to 34 C. Myocardial protection was obtained in all cases with a cold blood cardioplegic solution.
Statistical analysis
Nominal and ordinal data were described as absolute and relative frequencies and compared in a 2 x 2 table using the v 2 or the Fisher's exact test if one of the expected values in the 2 x 2 table was <5. The interval and ratio data were tested for normal distribution by a 1-sample Kolmogorov-Smirnov test. Normally distributed demographic and clinical patient data are presented as the mean and standard deviation and compared using the unpaired t-test. Not normally distributed data were described as the median and the 25th and 75th percentiles and compared using the Mann-Whitney U test. Data from patients suffering from cardiac arrest for <20 min and >20 min as well as from patients with out-of-hospital and in-hospital cardiac arrest were compared using the v 2 or the Fisher's exact test.
Age, ST-elevation myocardial infarction, non-ST-elevation myocardial infarction and all parameters with an association (P < _ 0.100) to death during the period < _30 days and >30 days in the univariate analyses (t-test, v 2 test and the Fisher's exact test) were included in multiple logistic regression analysis to assess their relative impact (adjusted odds ratio) on the number of deaths. The survival curve was estimated from right-censored data by means of the Kaplan-Meier analysis. Statistical analyses were performed using the statistical software SPSS (for Windows, Version 15.0, SPSS Inc., Chicago, IL, USA).
RESULTS
Patient characteristics
Between January 2001 and January 2015, 129 patients had had a CA preoperatively. Sixty patients (47%) experienced out-ofhospital CA; in 69 patients (53%), CA occurred while the person was under medical care-either while in transport or during the hospital stay prior to the operation. Patients were referred to our institution from 9 different hospitals and 1 practice. Ventricular fibrillation was the primary cause of arrhythmia in 92 cases (71%). In 25 patients (19%), >20 min were needed before spontaneous circulation returned. The mean age was 65 ± 10 years; 23 subjects (18%) were women. Eighty-four patients (65%) were diagnosed with STelevation myocardial infarction. CABG was performed within a median of 4 h (0.23-34.82 h; Table 1 ). Three-vessel coronary artery disease was present in 108 cases (84%). Left main stenosis occurred in 44 subjects (34%). PTCA was performed in 43 patients (33%), with a success rate of 21% (n = 9). Stents were implanted in 21 cases (16%). Twenty-three patients (18%) received acetylsalicylic acid combined with clopidogrel; 42 (33%) were treated with glycoprotein IIB/IIIa antagonists ( Table 2) .
Intraoperative details
The mean length of the operation was 210 ± 50 min; cardiopulmonary bypass time was 115 ± 39 min; and cross-clamp time was 59 ± 20 min. Most procedures were performed with the patient in cardioplegic arrest (n = 128, 99%). Ante-and retrograde cold blood cardioplegia was applied in 73 cases (57%). The mean number of distal anastomoses was 3.2 ± 0.8. Arterial grafts were used in 85 subjects (66%), with the left internal mammary artery in 63% (n = 81). A complete revascularization could be achieved in 106 cases (83%). Revascularization of the suspected vascular lesion was possible in 126 procedures (98%; Table 3 ).
Postoperative details
Fourteen patients (11%) suffered from low cardiac output syndrome. A patient was considered to have low cardiac output when a continuous infusion of catecholamines was necessary to maintain a systolic blood pressure above 90 mmHg and a cardiac output of >2.2 l/min/m 2 . Additionally, end-organ perfusion had to be impaired, most likely evident by oliguria or lactate levels exceeding 2 mmol/l. All patients were monitored by a SwanGanz pulmonary catheter. Rethoracotomy due to bleeding had to be performed in 11 patients (9%). Stroke rate was 9% (n = 11); hypoxic brain damage was documented in 12% (n = 16). A second myocardial infarction occurred in 2 patients (2%). In 9 cases (7%), an ECLS system was implanted (Table 3) .
Outcomes
The intraoperative mortality rate was 3% (n = 4). Thirty-day mortality was 23% (n = 30). Cause of death included persistent low cardiac output with multiple organ failure in 9 cases and withdrawal of treatment due to hypoxic brain injury in 6 individuals. The overall follow-up period covered a median of 4.9 years (range 0.4-13.4 years). Six patients were lost during follow-up. The mortality rate during this time was 30% (n = 27; Fig. 1 ). Of the 90 patients discharged alive, we had cerebral performance data from 86 (96%). Of those, 70 patients (79%) had a CPC scale of 1 or 2 (Table 4) .
Outcomes in patients with prolonged cardiac arrest
The outcomes of patients in whom >20 min went by until the return of spontaneous circulation were compared with the outcomes of those patients in whom <20 min were needed to regain cardiac output. As displayed in Table 5 , CA for >20 min resulted in a worse outcome with significantly more intraoperative deaths [n = 1 (0.9%) vs n = 3 (12.0%), P = 0.023]. Thirty-day mortality [n = 24 (24%) vs n = 6 (27%), P = 0.784] and long-term mortality [n = 21 (28%) vs n = 6 (40%), P = 0.081] rates were increased in patients with prolonged resuscitation, but numerical differences did not reach statistical significance. Although stroke rates did not differ, hypoxic brain damage occurred more often in the group with >20 min of CA [n = 9 (9%) vs n = 7 (32%), P = 0.016].
Outcomes in patients with out-of-hospital cardiac arrest
The outcomes of patients with out-of-hospital CA were compared with the outcomes of those who had to be resuscitated while under medical care-during transport, in hospital or periinterventionally. As demonstrated in Table 5 , out-of-hospital CA resulted significantly more often in downtimes >20 min [n = 19 (32%) vs n = 6 (9%), P = 0.002]. Although neither mortality (P = 0.081) nor stroke rates were found to be significantly different, more patients in the out-of-hospital CA group suffered from hypoxic brain damage [n = 14 (23%) vs n = 2 (3%), P = 0.0001].
Parameters associated with short-and long-term outcomes
Logistic regression analysis identified no PTCA prior to CABG as an independent risk factor for 30-day mortality (odds ratio 3.236, confidence interval 1.089-9.615). In addition, age (odds ratio 1.081, confidence interval 1.023-1.143) proved to have a significant influence on mortality during the follow-up period (Table 6 ).
DISCUSSION
AMI complicated by CA is associated with a dismal prognosis [9] . Large observational studies repeatedly supported the beneficial effects of early coronary angiography with PTCA in patients with ST-elevation myocardial infarction. However, this positive impact may also apply to patients with other electrocardiographic signs of myocardial ischaemia [3, 4] . Failure of PTCA occurs in approximately 10% of patients with confirmed coronary artery disease and CA, but these patients have rarely been discussed [1, 3, 10] . CABG may present a therapeutic option in this situation but is seldom considered, most likely due to the fear of fatal procedure-related complications. Our department liberally offers ECLS implantation and surgical revascularization to AMI patients with CA. We report the short-and long-term results of the patients undergoing CABG within a median of 4 h after CA occurred. The 30-day mortality rate was 23% with a slightly higher mortality rate of 30% observed during the follow-up period. Although any comparison with interventional treatmentbased studies is severely limited, these data show that the survival of patients with CA undergoing CABG may not be as disastrous as anticipated. For example, the Parisian Region Out of hospital Cardiac ArresT (PROCAT) registry reported a hospital mortality rate around 50% after out-of-hospital CA and successful PTCA [3] . The mortality rate during the follow-up period was approximately 37%. Data obtained from a comprehensive northern American prospective study showed an in-hospital mortality rate of 37% in CA patients after emergency PTCA when combined with therapeutic hypothermia [5] . As heterogeneous as patient populations are, CABG may offer a similar chance of survival for patients who currently are not considered for revascularizationa situation that is reflected by the relatively small percentage of study patients referred to CABG compared with the rate of patients where PTCA failed or was not attempted at all [1] .
Additionally, most studies focus on the management of patients after out-of-hospital CA, because these patients are at the highest risk for an unfavourable outcome due to the delayed initiation of or insufficient application of cardiopulmonary resuscitation measures. Our analysis also contains data about those subjects who had CA while under medical care. As expected, we observed significantly more cases of hypoxic brain damage after out-ofhospital CA. However, we did not find differences in mortality rates between patients with out-of-hospital CA and those undergoing resuscitation under medical care. This observation appears contradictory at first because the prompt initiation of cardiopulmonary resuscitation has been shown to increase survival rates in CA patients [9] . As comparable study data are missing, we assume these findings may at least partially be explained by the fact that 25% of CA cases under medical care occurred in the context of complications during interventional treatment. Patients in this situation probably suffered from additional severe myocardial ischaemia before CABG, which may have negatively influenced their outcome. In fact, all intraoperative deaths occurred after PTCA complications. This observation does not question the primary beneficial impact of PTCA in patients with CA. In fact, logistic regression analysis also identified preoperative PTCA as one factor that reduced the 30-day mortality rate. Nevertheless, these considerations support the conclusions drawn from interventional treatment-driven studies, demonstrating that failure or unfeasibility of PTCA reduces the chance of survival in CA patients with AMI [11] . Therefore, it is tempting to speculate whether an attempted percutaneous treatment is justified by all means possible instead of considering operative myocardial revascularization. Apart from the surgical trauma of sternotomy, the reluctance to transfer CA patients with AMI to CABG when PTCA has failed or diffuse coronary disease is present is based primarily on 2 fears: the fear of exposing these patients to the side effects of extracorporeal circulation and the fear of stroke. The use and potential benefits of ECLS systems, however, have recently reached the cardiology community [12, 13] . Although the general fear of exposing CA patients to some kind of extracorporeal circulation has subsided, the aversion towards on-pump procedures paradoxically remains solid. Few cardiologists know that extracorporeal circulation during CABG are conducted temperature-controlled. Mild hypothermia itself has been successfully implicated in improving neurological outcome after CA, especially in the context of AMI and early PTCA [5, [14] [15] [16] . Therefore, this particular feature may have contributed to the overall low incidence of neurological damage of 22% observed in this study.
In contrast, studies analysing the neurological outcome of patients after CA and interventional or conservative treatment consistently report neurological injuries in up to 50% of patients [1, 5, 15] . Because the diagnosis of brain damage after CA is not synonymous with irreversible loss of functionality in every case, several groups report the CPC scales of CA survivors. We were able to obtain CPC scales from 86 patients discharged alive. A majority of those patients demonstrated a good neurological outcome (CPC 1 and 2 ). In conclusion, our data indicate that onpump, temperature-controlled CABG may provide some distinct advantages, particularly in terms of neurological injury.
Given the fact that PTCA complications were associated with intraoperative deaths and the growing interdisciplinary knowledge about the potential benefits of early implantation of ECLS systems, we recommend that cardiologists and cardiac surgeons overcome their fear of performing CABG in CA patients unsuitable for PTCA. Instead, these data may provide a new incentive for an interdisciplinary heart team approach to improve the outcome in these vulnerable patients.
Study limitations
This study is a single-centre, small investigation. Therefore, any interpretation or comparison with reports focusing on the fate of patients with CA treated by PTCA is limited. In addition, data analyses of the initial hospital stay occurred retrospectively, so that some parameters could not be obtained. Finally, no control group could be generated due to the nature of this study. It remains unknown how many patients would have been eligible for CABG but were treated conservatively.
